30
Participants
Start Date
October 3, 2022
Primary Completion Date
October 31, 2024
Study Completion Date
December 31, 2024
Ketamine
Participants suffering from TRD will receive their ketamine treatment intravenously twice weekly for two weeks (4 treatments in total). A dose of 0.5 mg/kg is infused over 40 minutes, with dose adjustments made at the psychiatrist's discretion.
RECRUITING
St. Michael's Hospital, Toronto
Centre for Addiction and Mental Health
OTHER
Toronto Metropolitan University
OTHER
Unity Health Toronto
OTHER